Edesa Biotech, Inc.EDSANASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -0.77% |
| Q3 2025 | -12.35% |
| Q2 2025 | -31.29% |
| Q1 2025 | 332.75% |
| Q4 2024 | 9.23% |
| Q3 2024 | -30.37% |
| Q2 2024 | -34.30% |
| Q1 2024 | -27.51% |
| Q4 2023 | -19.76% |
| Q3 2023 | -13.07% |
| Q2 2023 | -15.07% |
| Q1 2023 | -19.35% |
| Q4 2022 | -4.72% |
| Q3 2022 | -23.41% |
| Q2 2022 | -37.64% |
| Q1 2022 | 55.38% |
| Q4 2021 | -19.74% |
| Q3 2021 | -17.45% |
| Q2 2021 | -27.97% |
| Q1 2021 | 115.79% |
| Q4 2020 | 7.96% |
| Q3 2020 | 17.86% |
| Q2 2020 | -23.96% |
| Q1 2020 | 40.57% |
| Q4 2019 | -19.01% |
| Q3 2019 | -51.59% |
| Q2 2019 | -84.54% |
| Q1 2019 | -16.54% |
| Q4 2018 | 514.49% |
| Q3 2018 | -92.47% |
| Q2 2018 | 27.40% |
| Q1 2018 | -21.25% |
| Q4 2017 | 469.62% |
| Q3 2017 | -88.14% |
| Q2 2017 | -12.36% |
| Q1 2017 | -9.87% |
| Q4 2016 | 511.44% |
| Q3 2016 | -80.67% |
| Q2 2016 | -13.07% |
| Q1 2016 | -9.31% |